SCHEMBL102190

SCHEMBL102190

CC=Cc1cc(C(=O)O)ccc1N1CCCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
CKS1B P61024 1/20 0.45
SKP1 P63208 1/20 0.45
SKP2 Q13309 1/20 0.45
GPR119 Q8TDV5 3/20 0.41
KDM4E B2RXH2 2/20 0.40
GAA P10253 2/20 0.40
MAPT P10636 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ABL1 P00519 1/20 0.40
RIN1 Q13671 1/20 0.40
USP30 Q70CQ3 1/20 0.39
SLC2A1 P11166 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL102189 1.00 KMT2A (0.48) KMT2AMEN1CKS1BSKP1SKP2
SCHEMBL106646 0.96 GPR119 (0.44) KMT2AMEN1CKS1BSKP1SKP2
SCHEMBL106647 0.96 GPR119 (0.44) KMT2AMEN1CKS1BSKP1SKP2
SCHEMBL103584 0.90 KMT2A (0.47) KMT2AMEN1CKS1BSKP1SKP2
SCHEMBL103583 0.90 KMT2A (0.47) KMT2AMEN1CKS1BSKP1SKP2
SCHEMBL104415 0.85 MEN1 (0.43) KMT2AMEN1CKS1BSKP1SKP2
SCHEMBL103065 0.85 NR1H2 (0.46) KMT2AMEN1GPR119KDM4EMAPT
SCHEMBL1481365 0.83 MEN1 (0.59) KMT2AMEN1CKS1BSKP1SKP2
SCHEMBL135247 0.82 SMARCA2 (0.47) GPR119USP30SMARCA2SMARCA4PBRM1
SCHEMBL135246 0.82 SMARCA2 (0.47) GPR119USP30SMARCA2SMARCA4PBRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2426113-B1 CARBINOL COMPOUND HAVING HETEROCYCLIC LINKER KOWA CO (JP) 2013-11-06 EP disclosed
US-8551985-B2 Carbinol derivatives having heterocyclic linker KOWA COMPANY, LTD. (JP) 2013-10-08 US disclosed
EP-2426113-A1 CARBINOL COMPOUND HAVING HETEROCYCLIC LINKER Kowa Company, Ltd. (JP) 2012-03-07 EP disclosed
US-20100280013-A1 CARBINOL DERIVATIVES HAVING HETEROCYCLIC LINKER KOWA COMPANY, LTD. (JP) 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280013-A1 CARBINOL DERIVATIVES HAVING HETEROCYCLIC LINKER NR1H2, NR1H3, CCR2 KMT2A 2327/4885MEN1 3479/4885CKS1B 509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.